Sakar Healthcare Limited — Board Meeting, 17-06-2025: Outcome of Board Meeting

Sakar Healthcare has announced the allotment of 3 lakh equity shares to non-promoter investors upon conversion of fully convertible warrants, increasing the paid-up capital to Rs. 22.25 Cr (2.22 crore shares of Rs. 10 each). The company received Rs. 8.64 Cr as 75% exercise price for these shares. With this conversion, all 5 lakh warrants issued earlier have been fully converted into equity, leaving no outstanding warrants. Key investors include Hi-Tech Chemicals Limited and individual allottees Hemant Gadodia, Prakash Diwan, and Sunil Kabra.